Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin Light-chain Amyloidosis”

256 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 256 results

Testing effectiveness (Phase 2)Study completedNCT02632786
What this trial is testing

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 129
Not applicableLooking for participantsNCT07689331
What this trial is testing

Hungarian National Systemic Amyloidosis Registry

Who this might be right for
Systemic AmyloidosisATTR AmyloidosisAL Amyloidosis+1 more
Semmelweis University 300
Testing effectiveness (Phase 2)Looking for participantsNCT07224672
What this trial is testing

Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis

Who this might be right for
Amyloidosis
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Looking for participantsNCT07151690
What this trial is testing

BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

Who this might be right for
Systemic Light Chain Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China 21
Not applicableLooking for participantsNCT07232459
What this trial is testing

[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis

Who this might be right for
AmyloidCardiac AmyloidosisAmyloidosis+1 more
Tianjin Medical University 25
Early research (Phase 1)Enrolling By InvitationNCT07771621
What this trial is testing

PET Imaging With [18F]Fluselenamyl in People With Cardiac Amyloidosis

Who this might be right for
Cardiac Amyloidosis
Washington University School of Medicine 50
Large-scale testing (Phase 3)Study completedNCT00004165
What this trial is testing

Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT03499808
What this trial is testing

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Who this might be right for
Amorphous, Eosinophilic, and Acellular DepositConstipationDiarrhea+10 more
SWOG Cancer Research Network 43
Early research (Phase 1)Study completedNCT05201911
What this trial is testing

Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis

Who this might be right for
Amyloidosis; Systemic
Attralus, Inc. 13
Testing effectiveness (Phase 2)Looking for participantsNCT06971380
What this trial is testing

Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis

Who this might be right for
Multiple Myeloma, Refractory to Standard TreatmentMultiple Myeloma, RelapsedLight Chain Amyloidosis
Polina Stepensky 180
Testing effectiveness (Phase 2)Looking for participantsNCT06342466
What this trial is testing

Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis

Who this might be right for
Systemic Amyloidosis
Jin Lu, MD 40
Testing effectiveness (Phase 2)UnknownNCT04316442
What this trial is testing

Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis

Who this might be right for
Light Chain (AL) Amyloidosis
Sorrento Therapeutics, Inc. 60
Testing effectiveness (Phase 2)WithdrawnNCT03130348
What this trial is testing

Ibrutinib With or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refractory Immunoglobulin Light Chain Amyloidosis

Who this might be right for
AmyloidosisImmunoglobulin Light Chain Deposition
Mayo Clinic
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00089167
What this trial is testing

Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT05951049
What this trial is testing

AT-02 in Subjects With Systemic Amyloidosis.

Who this might be right for
Amyloidosis; Systemic
Attralus, Inc. 120
Very early researchLooking for participantsNCT07626476
What this trial is testing

Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis

Who this might be right for
Relapsed/Refractory Light Chain AmyloidosisAL AmyloidosisSystemic Light Chain Amyloidosis
Beijing Boren Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05066607
What this trial is testing

Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy

Who this might be right for
AL Amyloidosis
Intergroupe Francophone du Myelome 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05451771
What this trial is testing

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

Who this might be right for
AL Amyloidosis
Columbia University 53
Testing effectiveness (Phase 2)Study completedNCT01083316
What this trial is testing

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 35
Next Page